4.8 Article

HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion

Journal

CELL REPORTS
Volume 17, Issue 4, Pages 949-956

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2016.09.077

Keywords

-

Categories

Funding

  1. European Research Council under European Union's Seventh Framework Programme /ERC Grant [320473-BacNK]
  2. Israel Science Foundation
  3. GIF Foundation
  4. ICRF professorship grant
  5. Israeli Science Foundation
  6. Helmholtz Israel grant
  7. Rosetrees Trust
  8. Rosetrees Trust [M21-F1] Funding Source: researchfish

Ask authors/readers for more resources

Herpes simplex virus 1 (HSV1) is a ubiquitous human pathogen that utilizes variable mechanisms to evade immune surveillance. The glycosylphosphatidylinositol (GPI) anchoring pathway is a multistep process in which a myriad of different proteins are covalently attached to a GPI moiety to be presented on the cell surface. Among the different GPI-anchored proteins there are many with immunological importance. We present evidence that the HSV1-encoded miR H8 directly targets PIGT, a member of the protein complex that covalently attaches proteins to GPI in the final step of GPI anchoring. This results in a membrane down-modulation of several different immune-related, GPI-anchored proteins, including ligands for natural killer-activating receptors and the prominent viral restriction factor tetherin. Thus, we suggest that by utilizing just one of dozens of miRNAs encoded by HSV1, the virus can counteract the host immune response at several key points.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Anti-RhD antibody therapy modulates human natural killer cell function

Shlomo Elias, Inbal Kol, Shira Kahlon, Rajaa Amore, Mariam Zeibak, Dror Mevorach, Uriel Elchalal, Orly Zelig, Ofer Mandelboim

Summary: Anti-RhD antibodies are used to prevent RhD immunization, potentially by inducing NK cell degranulation. The mechanism involves CD16 activation and glycosylation of the antibodies. Additionally, the RhD drug may enhance killing of dendritic cells.

HAEMATOLOGICA (2021)

Article Virology

Altered NKp46 Recognition and Elimination of Influenza B Viruses

Alexandra Duev-Cohen, Batya Isaacson, Orit Berhani, Yoav Charpak-Amikam, Nehemya Friedman, Yaron Drori, Michal Mandelboim, Ofer Mandelboim

Summary: The study found that NKp46 can recognize influenza B viruses, but the interaction strength is weaker compared to influenza A, and NKp46 is not crucial for eliminating influenza B.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain

Einat Seidel, Liat Dassa, Shira Kahlon, Boaz Tirosh, Anne Halenius, Tal Seidel Malkinson, Ofer Mandelboim

Summary: The study reveals that the glycoprotein US9 of human cytomegalovirus downregulates the activating immune ligand MICA*008 by slow cleavage of its signal peptide, leading to retention and degradation in the endoplasmic reticulum (ER) via the ER quality control system.

NATURE COMMUNICATIONS (2021)

Article Microbiology

The human cytomegalovirus protein UL147A downregulates the most prevalent MICA allele: MICA*008, to evade NK cell-mediated killing

Einat Seidel, Liat Dassa, Corinna Schuler, Esther Oiknine-Djian, Dana G. Wolf, Vu Thuy Khanh Le-Trilling, Ofer Mandelboim

Summary: The study reveals that the uncharacterized HCMV protein UL147A interferes with the immune response by downregulating the expression of the immune ligand MICA*008, hindering the elimination of HCMV-infected cells. This finding advances the understanding of complex HCMV immune evasion mechanisms and may facilitate the development of antiviral drugs and vaccines.

PLOS PATHOGENS (2021)

Article Immunology

The inhibitory receptor CD300a is essential for neutrophil-mediated clearance of urinary tract infection in mice

Batya Isaacson, Maya Baron, Rachel Yamin, Gilad Bachrach, Francesca Levi-Schaffer, Zvi Granot, Ofer Mandelboim

Summary: CD300a plays a crucial role in the neutrophil-mediated immune response to UPEC-induced urinary tract infection. Deficiency of CD300a impairs phagocytic abilities of neutrophils, leading to severe exacerbation of infection.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Review Dentistry, Oral Surgery & Medicine

Immune Changes Induced by Orthodontic Forces: A Critical Review

S. Chaushu, Y. Klein, O. Mandelboim, Y. Barenholz, O. Fleissig

Summary: The review critically summarizes the immune processes involved in orthodontic tooth movement (OTM) inflammation and provides insights into the relationship between classical inflammation and clinical OTM phases. Recent studies highlight the existence of a typical innate immune response in OTM, with partial resolution observed in the lag phase. Future studies are needed to further uncover cellular and molecular immune targets for developing strategies to control OTM through modulation of the inflammatory process.

JOURNAL OF DENTAL RESEARCH (2022)

Article Multidisciplinary Sciences

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, Yiska Weisblum, Fabian Schmidt, Marina Caskey, Christian Gaebler, Alice Cho, Marianna Agudelo, Shlomo Finkin, Zijun Wang, Daniel Poston, Frauke Muecksch, Theodora Hatziioannou, Paul D. Bieniasz, Davide F. Robbiani, Michel C. Nussenzweig, Pamela J. Bjorkman, Jesse D. Bloom

Summary: The study found that although the human immune system can produce antibodies that target diverse RBD epitopes, in practice, the polyclonal response to infection tends to be skewed towards a single class of antibodies targeting an epitope that is already undergoing rapid evolution.

NATURE COMMUNICATIONS (2021)

Article Immunology

Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation

Johanna Galaski, Amjad Shhadeh, Ariana Umana, Christopher C. Yoo, Ludovica Arpinati, Batya Isaacson, Orit Berhani, Bernhard B. Singer, Daniel J. Slade, Gilad Bachrach, Ofer Mandelboim

Summary: F. nucleatum binds and activates CEACAM1 through its surface protein CbpF, leading to inhibition of CD4(+) T cell response and promotion of tumorigenesis.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Letter Medicine, General & Internal

Plasma Neutralization of the SARS-CoV-2 Omicron Variant

Fabian Schmidt, Frauke Muecksch, Yiska Weisblum, Justin Da Silva, Eva Bednarski, Alice Cho, Zijun Wang, Christian Gaebler, Marina Caskey, Michel C. Nussenzweig, Theodora Hatziioannou, Paul D. Bieniasz

Summary: Neutralization assays showed much lower omicron neutralization compared to Wuhan-hu-1 after two doses of mRNA vaccine, but individuals who received a booster vaccine or were vaccinated after recovering from Covid-19 exhibited high levels of omicron neutralization.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

Replication and single-cycle delivery of SARS-CoV-2 replicons

Inna Ricardo-Lax, Joseph M. Luna, Tran Thi Nhu Thao, Jeremie Le Pen, Yingpu Yu, H-Heinrich Hoffmann, William M. Schneider, Brandon S. Razooky, Javier Fernandez-Martinez, Fabian Schmidt, Yiska Weisblum, Bettina Salome Trueb, Ines Berenguer Veiga, Kimberly Schmied, Nadine Ebert, Eleftherios Michailidis, Avery Peace, Francisco J. Sanchez-Rivera, Scott W. Lowe, Michael P. Rout, Theodora Hatziioannou, Paul D. Bieniasz, John T. Poirier, Margaret R. MacDonald, Volker Thiel, Charles M. Rice

Summary: Molecular virology tools are crucial for studying SARS-CoV-2 and developing therapeutics. A yeast-based reverse genetics system was used to create spike-deleted self-replicating RNAs for SARS-CoV-2. These noninfectious replicons can be complemented with viral glycoproteins for single-cycle delivery into different cell types, making it a versatile platform for antiviral drug screening and viral variant characterization.

SCIENCE (2021)

Article Biology

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape

Fred D. Mast, Peter C. Fridy, Natalia E. Ketaren, Junjie Wang, Erica Y. Jacobs, Jean Paul Olivier, Tanmoy Sanyal, Kelly R. Molloy, Fabian Schmidt, Magdalena Rutkowska, Yiska Weisblum, Lucille M. Rich, Elizabeth R. Vanderwall, Nicholas Dambrauskas, Vladimir Vigdorovich, Sarah Keegan, Jacob B. Jiler, Milana E. Stein, Paul Dominic B. Olinares, Louis Herlands, Theodora Hatziioannou, D. Noah Sather, Jason S. Debley, David Fenyo, Andrej Sali, Paul D. Bieniasz, John D. Aitchison, Brian T. Chait, Michael P. Rout

Summary: Researchers generated a large nanobody repertoire to target distinct and highly conserved epitopes on the SARS-CoV-2 spike protein, identifying new nanobody binding sites that can inhibit viral infection and combat viral variants effectively.

ELIFE (2021)

Article Microbiology

VPS29 Exerts Opposing Effects on Endocytic Viral Entry

Daniel Poston, Yiska Weisblum, Alvaro Hobbs, Paul D. Bieniasz

Summary: These data identify a host pathway by which VPS29 and associated factors control the endosomal environment and influence susceptibility to viral infection. This pathway could serve as a pharmaceutical target for intervention in zoonotic viral diseases, including those caused by coronaviruses, influenza viruses, and filoviruses, all of which are pandemic threats.
Article Multidisciplinary Sciences

Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT

Yoav Charpak-Amikam, Tom Lapidus, Batya Isaacson, Alexandra Duev-Cohen, Tal Levinson, Adi Elbaz, Francesca Levi-Schaffer, Nir Osherov, Gilad Bachrach, Lois L. Hoyer, Maya Korem, Ronen Ben-Ami, Ofer Mandelboim

Summary: This study identifies how Candida albicans evades the immune response by manipulating the immune checkpoint receptor TIGIT. The results suggest that immunotherapy using a TIGIT-blocking antibody can restore anti-Candida immunity and serve as a potential therapeutic tool.

NATURE COMMUNICATIONS (2022)

Article Biology

Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry

Edward R. Kastenhuber, Marisa Mercadante, Benjamin Nilsson-Payant, Jared L. Johnson, Javier A. Jaimes, Frauke Muecksch, Yiska Weisblum, Yaron Bram, Vasuretha Chandar, Gary R. Whittaker, Benjamin R. tenOever, Robert E. Schwartz, Lewis Cantley

Summary: Coagulopathy is a significant aspect of morbidity in COVID-19 patients. This study demonstrates that coagulation factors Xa and thrombin can directly cleave SARS-CoV-2 spike, enhancing viral entry. Protease inhibitors, such as nafamostat and camostat, can inhibit spike cleavage and may have potential therapeutic effects. Anticoagulation is critical in managing COVID-19, and early intervention could provide additional benefits by suppressing viral entry.

ELIFE (2022)

Article Gastroenterology & Hepatology

Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection

Julia A. Brown, Katherine Z. Sanidad, Serena Lucotti, Carolin M. Lieber, Robert M. Cox, Aparna Ananthanarayanan, Srijani Basu, Justin Chen, Mengrou Shan, Mohammed Amir, Fabian Schmidt, Yiska Weisblum, Michele Cioffi, Tingting Li, Florencia Madorsky Rowdo, M. Laura Martin, Chun-Jun Guo, Costas Lyssiotis, Brian T. Layden, Andrew J. Dannenberg, Paul D. Bieniasz, Benhur Lee, Naohiro Inohara, Irina Matei, Richard K. Plemper, Melody Y. Zeng

Summary: This study reveals the mechanisms by which the gut microbiome protects mammalian hosts from SARS-CoV-2 infection. Short-chain fatty acids reduce viral burden by regulating the viral entry receptor and enhancing adaptive immunity, while also regulating systemic coagulation by limiting megakaryocyte proliferation. These findings have significant implications for understanding the immune and coagulation mechanisms of COVID-19 infection.

GUT MICROBES (2022)

No Data Available